Patent details

Basic Information

Publication number:

EP2907826

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP151617792

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN SIGLEC-15

French Title of Invention:

ANTICORPS CIBLANT LA PROTÉINE SIGLEC-15 DE TYPE OSTÉOCLASTE

German Title of Invention:

AUF DAS OSTEOKLASTENABHÄNGIGE PROTEIN SIGLEC-15 GERICHTETER ANTIKÖRPER

SPC Number:

Dates

Filing date:

08/10/2008

Grant date:

30/05/2018

EP Publication Date:

19/08/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/05/2018

EP B1 Publication Date:

30/05/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/10/2018

Expiration date:

08/10/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/05/2018

 

 

Name:

Daiichi Sankyo Company, Limited

Address:

3-5-1, Nihonbashi Honcho, Chuo-ku Tokyo 103-8426, Japan (JP)

Inventor

1

Name:

Hiruma, Yoshiharu

Address:

Japan (JP)

2

Name:

Tsuda, Eisuke

Address:

Japan (JP)

Priority

Priority Number:

2007265420

Priority Date:

11/10/2007

Priority Country:

Japan (JP)

Classification

IPC classification:

A61K 31/122; A61K 31/352; A61K 31/565; A61K 31/593; A61K 31/663; A61K 38/23; A61K 39/395; A61K 45/00; A61P 19/08; A61P 19/10; C07K 16/18; C07K 16/28; C12N 5/10; C12P 21/08;

Publication

European Patent Bulletin

Issue number:

201822

Publication date:

30/05/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/02/2019	Outgoing Correspondence	1